Showing results (191-200 of 1,098) with videos related to
Sort By:
Pageof 110
Diabetes Research and Clinical Practice|November 3, 2017
Long exposure to type 2 diabetes and risk of non-fatal coronary heart disease in Chinese females and males: Findings from a China national cross-sectional studyJing Li, Yingying Luo, Xiaohui Guo, et al.Journal of Diabetes Investigation|October 14, 2017
No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.Diabetes Technology & Therapeutics|December 6, 2016
DPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-AnalysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.Diabetes Research and Clinical Practice|October 20, 2009
Risk factors associated with the presence of diabetes in Chinese communities in BeijingXianghai Zhou, Linong Ji, Yingying Luo, et al.Diabetes/Metabolism Research and Reviews|January 10, 2018
Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: An analysis of the ORBIT studyHua Shu, Juming Lu, Puhong Zhang, et al.Frontiers in Endocrinology|May 26, 2022
Association Between Indices of Body Composition and Metabolically Unhealthy Phenotype in China: A Cross-Sectional StudyFang Lv, Xiaoling Cai, Yufeng Li, et al.Journal of Diabetes Investigation|May 21, 2014
Association of serine racemase gene variants with type 2 diabetes in the Chinese Han populationSimin Zhang, Jianzhong Xiao, Qian Ren, et al.BMC Endocrine Disorders|May 23, 2021
A case report of pseudohypoaldosteronism type II with a homozygous KLHL3 variant accompanied by hyperthyroidismRui Zhang, Simin Zhang, Yingying Luo, et al.Expert Review of Clinical Pharmacology|January 31, 2025
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trialsYiran Wang, Zonglin Li, Chu Lin, et al.Diabetes, Obesity & Metabolism|August 9, 2024
Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China studyLinong Ji, Yiming Mu, Cuiqing Chang, et al.Pageof 110